Back to Search Start Over

Preparation of Compound Salvia miltiorrhiza–Blumea balsamiferaNanoemulsion Gel and Its Effect on Hypertrophic Scars in the Rabbit Ear Model

Authors :
Chen, Teng
Wang, Zuhua
Gong, Xingchu
Zhang, Jiaojiao
Zhang, Ning
Yang, Jing
Zhu, Yue
Zhou, Ying
Source :
Molecular Pharmaceutics; May 2024, Vol. 21 Issue: 5 p2298-2314, 17p
Publication Year :
2024

Abstract

Hypertrophic scars (HS) still remain an urgent challenge in the medical community. Traditional Chinese medicine (TCM) has unique advantages in the treatment of HS. However, due to the natural barrier of the skin, it is difficult for the natural active components of TCM to more effectively penetrate the skin and exert therapeutic effects. Therefore, the development of an efficient drug delivery system to facilitate enhanced transdermal absorption of TCM becomes imperative for its clinical application. In this study, we designed a compound Salvia miltiorrhiza–Blumea balsamiferananoemulsion gel (CSB-NEG) and investigated its therapeutic effects on rabbit HS models. The prescription of CSB-NEG was optimized by single-factor, pseudoternary phase diagram, and central composite design experiments. The results showed that the average particle size and PDI of the optimized CSB-NE were 46.0 ± 0.2 nm and 0.222 ± 0.004, respectively, and the encapsulation efficiency of total phenolic acid was 93.37 ± 2.56%. CSB-NEG demonstrated excellent stability and skin permeation in vitroand displayed a significantly enhanced ability to inhibit scar formation compared to the CSB physical mixture in vivo. After 3 weeks of CSB-NEG treatment, the scar appeared to be flat, pink, and flexible. Furthermore, this treatment also resulted in a decrease in the levels of the collagen I/III ratio and TGF-ß1and Smad2 proteins while simultaneously promoting the growth and remodeling of microvessels. These findings suggest that CSB-NEG has the potential to effectively address the barrier properties of the skin and provide therapeutic benefits for HS, offering a new perspective for the prevention and treatment of HS.

Details

Language :
English
ISSN :
15438384 and 15438392
Volume :
21
Issue :
5
Database :
Supplemental Index
Journal :
Molecular Pharmaceutics
Publication Type :
Periodical
Accession number :
ejs65869711
Full Text :
https://doi.org/10.1021/acs.molpharmaceut.3c01091